Gemcitabine: End of a Chemotherapy's Era?
Acta Haematol
.
2019;141(2):91-92.
doi: 10.1159/000496098.
Epub 2019 Jan 10.
Author
Stephen D Smith
1
Affiliation
1
Department of Internal Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington, USA, ssmith50@seattlecca.org.
PMID:
30630165
DOI:
10.1159/000496098
No abstract available
Publication types
Editorial
Comment
MeSH terms
Deoxycytidine / analogs & derivatives
Gemcitabine
Humans
Lymphoma, Non-Hodgkin*
Salvage Therapy*
Substances
Deoxycytidine
Gemcitabine